Exceptional discounts on smart lighting to transform living spaces for less
SEATTLE, July 2, 2025 /PRNewswire/ -- Govee, a leading innovator in smart lighting is...
SHENZHEN, China, June 20, 2025 /PRNewswire/ -- NEEWER, a leader in professional photography equipment, today announced the global online launch of its new NEEWER...
Presenting a new collection of objects co-created with visionary Danish designers and MycoWorks - curated by Marie-Louise Høstbo.
3 Days of Design, Copenhagen 2025,
June 18...
CARDIFF, United Kingdom, June 17, 2025 (GLOBE NEWSWIRE) -- Llusern Scientific, a point-of-care diagnostics company, announces it has been awarded ISO 13485 certification for its Lodestar DX testing system, a rapid molecular diagnostic platform for urinary tract infections (UTIs). With industry-leading accuracy and speed, Lodestar DX empowers clinicians to diagnose and rule-out infections with precision in a single visit, thereby improving patient outcomes.
Evolution Where It Matters Most. Trusted Outdoor Performance, Now Refined.
BETHLEHEM, Pa., June 17, 2025 /PRNewswire/ -- OM Digital Solutions Corporation proudly announces the launch...
Guangzhou, China, June 14, 2025 (GLOBE NEWSWIRE) -- From June 9 to 12, 2025, the 30th Guangzhou International Lighting Exhibition (GILE) was grandly held at the China Import and Export Fair Complex in Guangzhou, bringing together over 3,000 exhibitors worldwide. With the theme "AI + 3D Printing: Pioneering a New Era of Lighting," YD Illumination unveiled a 200+ square-meter double-decker exhibition hall, showcasing its latest lighting innovations and AI-powered 3D printing breakthroughs, drawing significant attention from industry professionals.
WASHINGTON, June 12, 2025 /PRNewswire/ -- The U.S. Consumer Product Safety Commission (CPSC) is warning consumers to immediately stop using Joyracer 500w Dirt Quad...
WOBURN, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company focused on the development and commercialization of photodynamic therapy (PDT), confirms a disclosure by the Management Board of Biofrontera AG on June 10, 2025, according to which the two companies are in negotiations regarding a possible combination of the two companies or an adjustment of the license and supply agreement between them. The latter could result in the transfer of certain rights and obligations from Biofrontera AG to Biofrontera Inc. and a reduction in the transfer price for Biofrontera Inc.’s licensed products sold in the US.